Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing number of cannabis companies expanding their CBD capabilities, following the major market trends for 2019.

Every company and investor in the cannabis industry is well aware of the hype surrounding the potential for CBD and hemp. You can find a plethora of articles flooding the news about this sector, and the hype seems well justified according to research from New Frontier Data.  

The momentum of CBD is making everyone take notice and many cannabis companies are not wasting this momentum for CBD, investing in new partnerships and business changes to ensure a strong position for the future.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) recently announced that it has entered into a multi-year extraction services contract with Valens GroWorks Corp. to have the first organically certified hemp-derived CBD products for Canada.

TGOD has been working closely with Valens to help expedite the pathway to organic certification for Valens organic processing methodologies. Upon certification, TGOD will have exclusive access to services provided by Valens for certified organic extraction processing for a period of 1 year.

Being first to market in Canada with organically certified hemp-derived CBD products allows TGOD to capture the organic CBD market share, securing future growth in this newly legalized cannabinoid vertical.

Golden Developing Solutions, Inc. (OTC: DVLP), an emerging company in the cannabis and CBD space  is also making progress in the CBD  market, having just announced the completion of its acquisition of Infusionz, LLC (CBD Infusionz), a manufacturer of CBD based products.

"CBD Infusionz is a true leadership play in the CBD space, with rapidly growing sales and the best quality products in the industry. This is the company that developed and launched one of the first edibles in the legal marijuana space and now they have created the best acquisition in the CBD space. Our business is growing exponentially with massive upside with capital improvements and operational sophistication. We strongly believe this acquisition adds an enormous dose of value for DVLP and its shareholders," noted the Company's CEO, Stavros Triant.

Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), a vertically integrated cannabis leader with core operations in Latin America is looking to introduce its CBD brand to new consumers and international markets, having announced that they will participate in Cosmoprof Worldwide Bologna, taking place March 14-17 in Bologna, Italy. Recognized as the largest and most important event in the beauty buyers' calendar, this event brings the Company's Kuida® cosmeceutical portfolio to a global network of retail buyers and distributors.

Andres Galofre, Co-founder and VP Business Development, Khiron Life Sciences Corp., states, "Our participation in Cosmoprof Worldwide Bologna marks an important milestone for Khiron as we bring the Kuida® brand to the global market for the first time. As well, we will be educating beauty buyers about cannabis legislation in their jurisdiction as it applies to CBD-based cosmeceuticals, and increase awareness of the market potential in this fast developing category."

Launched in Colombia in October 2018 through retail, wholesale and online channels, Kuida® will now target the global skincare market which, according to Euromonitor International, is expected to reach US$131 Billion in 2019.

SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) is looking more into supply than brand awareness, having announced that it has signed a binding letter of intent to acquire three tracts of agricultural property totaling 568 acres of land in the States of Tennessee and Kentucky for the cultivation and production of raw hemp biomass.

The Company will assign the agricultural property to its hemp/CBD-focused subsidiary, Heavenly Rx Ltd, which will allow Heavenly to fill future national or international orders using its own farms and supply agreements, a key development in Heavenly's strategic plan to become a vertically-integrated leader in the hemp and CBD marketplaces.

CBD/Hemp seems to be taking the spotlight away from its THC/Cannabis counterpart, due mainly to the fact that it is non-psychoactive, “healthy” approved, now less regulated and generally less socially stigmatized against.  More and more companies are planning their futures around this very change.

We may never see a high number of THC/cannabis products sold in grocery stores and pharmacies, but CBD products will certainly be hitting shelves near you soon, if they aren’t there already.